Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With <i>MEK</i> Mutation and <i>PIK3CA</i> Amplification Achieved by Dual Trametinib and Metformin Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

Published:2022-05 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Remenár Éva¹^ORCID,Dóczi Róbert²^ORCID,Dirner Anna²,Sipos Anna²,Perjési Anita²,Tihanyi Dóra²,Vodicska Barbara²^ORCID,Lakatos Dóra²^ORCID,Horváth Katalin³,Kajáry Kornélia⁴,Schwáb Richárd²⁵,Déri Júlia²,Lengyel Csongor György²^ORCID,Várkondi Edit²,Vályi-Nagy István⁶,Peták István²⁷⁸^ORCID

Affiliation:

1. Buda Hospitaller Order of St John of God, Budapest, Hungary

2. Oncompass Medicine Hungary Ltd, Budapest, Hungary

3. National Institute of Oncology, Budapest, Hungary

4. Pozitron-Diagnostics Health Centre, Budapest, Hungary

5. MiND Klinika Kft, Budapest, Hungary

6. Centrum Hospital of Southern Pest, National Hematology and Infectology Institute, Budapest, Hungary

7. Department of Pharmacology, Semmelweis University, Budapest, Hungary

8. Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00344

Reference46 articles.

1. The PI3K Pathway As Drug Target in Human Cancer

2. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

3. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer

4. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2

5. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azathioprine/metformin/trametinib;Reactions Weekly;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3